BCAX · Bicara Therapeutics Inc.
$23.90
-0.49 (-2.01%)
At close · Aug 21
Market Cap
$1.58B
Shares
66.17M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-08-11 | — | |
| 10-Q | 2026-08-11 | 2026-06-30 | |
| 8-K | 2026-07-28 | 2026-07-23 | |
| 8-K | 2026-06-10 | 2026-06-09 | |
| 8-K | 2026-05-21 | — | |
| 8-K | 2026-05-11 | — | |
| 10-Q | 2026-05-11 | 2026-03-31 | |
| DEF 14A | 2026-04-27 | 2026-04-21 | |
| 10-K | 2026-03-30 | 2025-12-31 | |
| 8-K | 2026-03-30 | — | |
| 8-K | 2026-02-26 | 2026-02-24 | |
| 8-K | 2026-02-19 | — | |
| 8-K | 2026-01-12 | — | |
| 8-K | 2025-12-08 | 2025-12-06 | |
| 10-Q | 2025-11-10 | 2025-09-30 | |
| 8-K | 2025-11-10 | — | |
| 10-Q | 2025-08-12 | 2025-06-30 | |
| 8-K | 2025-08-12 | — | |
| 8-K | 2025-06-12 | 2025-06-09 | |
| 8-K | 2025-06-06 | 2025-06-02 | |
| 8-K | 2025-05-13 | — | |
| 10-Q | 2025-05-13 | 2025-03-31 | |
| DEF 14A | 2025-04-25 | 2025-06-09 | |
| 10-K | 2025-03-27 | 2024-12-31 | |
| 8-K | 2025-03-27 | — | |
| 8-K | 2025-01-13 | — | |
| 10-Q | 2024-11-12 | 2024-09-30 | |
| 8-K | 2024-11-12 | — | |
| 8-K | 2024-09-16 | 2024-09-12 |
Showing 1–29 of 29 filings
Key facts
CIK
2023658
CUSIP
055477103
13F (30d)
163 filings
160 filers
Visit website
Investor relations